Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Ordinary Shares, nominal value of $0.01 per share
-
Shares outstanding
-
2,461,355,158
-
Number of holders
-
15
-
Total 13F shares, excl. options
-
1,941,513
-
Shares change
-
+1,941,513
-
Total reported value, excl. options
-
$19,803,000
-
Value change
-
+$19,803,000
-
Number of buys
-
15
-
Price
-
$10.20
Significant Holders of Sofgen Pharma S.A. - Ordinary Shares, nominal value of $0.01 per share (PROCF) as of Q3 2021
15 filings reported holding PROCF - Sofgen Pharma S.A. - Ordinary Shares, nominal value of $0.01 per share as of Q3 2021.
Sofgen Pharma S.A. - Ordinary Shares, nominal value of $0.01 per share (PROCF) has 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,941,513 shares
of 2,461,355,158 outstanding shares and own 0.08% of the company stock.
Largest 10 shareholders include COMPASS GROUP LLC (753,612 shares), BERKLEY W R CORP (327,795 shares), Sectoral Asset Management Inc (274,275 shares), D. E. Shaw & Co., Inc. (195,303 shares), Itau Unibanco Holding S.A. (120,000 shares), HRT FINANCIAL LP (56,654 shares), Fort Baker Capital Management LP (50,212 shares), CITADEL ADVISORS LLC (44,898 shares), Kepos Capital LP (40,800 shares), and JPMORGAN CHASE & CO (25,106 shares).
This table shows the top 15 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.